2,290
Views
2
CrossRef citations to date
0
Altmetric
Original Research

ADAM12 abrogation alters immune cell infiltration and improves response to checkpoint blockade therapy in the T11 murine model of triple-negative breast cancer

, , &
Article: 2158006 | Received 01 Jun 2022, Accepted 08 Dec 2022, Published online: 16 Dec 2022